Randomised Clinical Trial: The Efficacy and Safety of Oltipraz, a Liver X Receptor Alpha-Inhibitory Dithiolethione in Patients With Non-Alcoholic Fatty Liver Disease

Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.13981
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy